BDH Industries Limited (BOM:524828)

Market Cap	2.36B +23.8%
Revenue (ttm)	851.11M +12.3%
Net Income	104.23M +6.9%
EPS	18.11 +7.0%
Shares Out	5.76M
PE Ratio	22.65
Forward PE	n/a
Dividend	4.50 (1.08%)
Ex-Dividend Date	Aug 1, 2025

Volume	2,161
Average Volume	5,147
Open	412.00
Previous Close	400.00
Day's Range	406.15 - 435.00
52-Week Range	241.00 - 523.75
Beta	0.07
RSI	60.77
Earnings Date	Feb 11, 2026

About BDH Industries

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-e...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 112
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524828

Financial Performance

In fiscal year 2025, BDH Industries's revenue was 665.08 million, a decrease of -22.51% compared to the previous year's 858.31 million. Earnings were 92.73 million, a decrease of -6.02%.